Skip to main content
MedPathMedPath Home
Clinical Trials/PACTR201902822178026
PACTR201902822178026
Completed
未知

A randomized controlled double-blind study comparing dexmedetomidine and esmolol effects on Cardiac recovery in patients undergoing valve replacement surgery.

menoufia university hospitals0 sites120 target enrollmentFebruary 12, 2019
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
menoufia university hospitals
Enrollment
120
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 12, 2019
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
menoufia university hospitals

Eligibility Criteria

Inclusion Criteria

  • •patients aged 18\-70 years old,
  • •ASA I\-III,
  • •of both sexes
  • •undergoing valve replacement surgery

Exclusion Criteria

  • •Patients refused to take part in the study,
  • •allergic to esmolol and dexmedetomidine,
  • •history of ß\-blocker or dexmedetomidine intake,
  • •history of cardiac conduction abnormalities
  • •and with pericarditis

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 3
A double-blind randomized controlled trial comparing 0.75mg of Palonosetron with 1mg of Granisetron for the control of highly emetogenic chemotherapy-induced emesis.Malignant tumor (lung cancer,gastric cancer,esophagus cancer,cervical cancer,endometrial cancer,head and neck cancer,etc)
JPRN-UMIN000004863Pharma Valley Center,Shizuoka Organization for Creation Industries840
Completed
Phase 3
A double-blind randomized controlled trial comparing 3mg and 1mg of ranisetron for the control of chemotherapy-induced acute emesisMalignant tumor (breast cancer, lung cancer, gastric cancer, esophagus cancer, colorectal cancer, etc)
JPRN-UMIN000000984Pharma Valley Center, Shizuoka Organization for Creation Industries360
Completed
Not Applicable
A double-blind randomized controlled trial comparing PArietene self-fixing semi-Resorbable mesh with standard heavy-weight polypropylene mesh on chronic inguinal pAin DEvelopmentChronic pain after inguinal hernia repair10041297
NL-OMON31651Tyco Health Care350
Active, not recruiting
Phase 1
A clinical study to assess the efficacy of Orelvo (voclosporin) compared with placebo in achieving renal response after 24 weeks of therapy in subjects with active lupus nephritis (LN)upus NephritisMedDRA version: 21.1 Level: PT Classification code 10025140 Term: Lupus nephritis System Organ Class: 10038359 - Renal and urinary disordersTherapeutic area: Diseases [C] - Immune System Diseases [C20]
EUCTR2016-004045-81-PLAurinia Pharmaceuticals, Inc.324
Active, not recruiting
Phase 1
A clinical study to assess the efficacy of Orelvo (voclosporin) compared with placebo in achieving renal response after 24 weeks of therapy in subjects with active lupus nephritis (LN)Active Lupus NephritisMedDRA version: 19.1Level: PTClassification code 10025140Term: Lupus nephritisSystem Organ Class: 10038359 - Renal and urinary disordersTherapeutic area: Diseases [C] - Immune System Diseases [C20]
EUCTR2016-004045-81-ESAurinia Pharmaceuticals, Inc.324